Breast Cancer Clinical Trial
Official title:
The Effect of Two Different Methods of Health Education on Self-Efficacy and Health Beliefs of Mammography and Participation in the Screening Program of 40-69 Age Group Women
Objective: In this study, it was aimed to determine the effects of health education provided by two different methods on breast cancer and mammography knowledge self-evaluation status, perceived mammography benefit and barrier levels, mammography self-efficacy levels and mammography screening of women aged 40-69 years. Materials and Methods: The study was conducted in a parallel group design as a single-blind randomized controlled trial. The sample consisted of 126 healthy volunteers, 42 in each group, who were registered to Toprakkale Family Health Center between January and July 2023, met the inclusion criteria. In the study, 10-unit Visual Analogue Scale, mammography benefit and obstacle perception sub-dimension of Champion's Health Belief Model Scale and Mammography Self-Efficacy Scale were used for self-assessment of breast cancer and mammography knowledge. In the study, while the control group received standard care, the face-to-face education group was given health education and brochures through home visits, and a reminder interview was made over the phone. Health education and digital brochures were given to the online training group via video call, and a reminder meeting was held once. After a two-month follow-up, One-Way Analysis of Variance and Kruskal Wallis H test were used to compare the data of the three groups, multiple comparisons were analyzed with Tukey's test and Dunn's test. Generalized Linear Models were used for group and time comparisons.
This study was conducted as a parallel group, single-blind randomized controlled trial. The study was carried out in Osmaniye Province Toprakkale Family Health Center between January - July 2023. In this study, it was calculated that at least 96 participants should be included in three groups with effect size d=0.18, 95% power and 0.05 error level. G Power 3.1.9.2 package program was used in the calculation. Considering the possible data loss in the study, it was decided to add 30% of the participants. In this context, the sample of the study was determined as 126 participants, 42 in each group. After briefing the women aged 40-69 who came to the FHC for any reason about the purpose of the study, the researcher invited them to participate in the study. Subsequently, it examined the inclusion criteria of women who volunteered to participate in the study. The purpose of the study was explained to the participants who met the inclusion criteria and Form I was administered to the participants. In the randomization of the participants, the block randomization method was preferred. Following the administration of Form I, the participants were assigned to the group in the block randomization list according to the order of arrival at the FHC. No intervention was made to the control group during the application process. Participants in the online training group received online health training and a digital training brochure. Participants in the face-to-face training group received face-to-face health education through home visits and a training brochure. Four weeks later, the participants in the online and face-to-face training groups were given a telephone reminder call. At the end of eight weeks, Form II was administered to all groups. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |